1. Bray, F. et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 68, 394–424 (2018).
2. Ferlay J. et al. Cancer Today (Powered by GLOBOCAN 2018): IARC CancerBase No. 15. IARC https://publications.iarc.fr/Databases/Iarc-Cancerbases/Cancer-Today-Powered-By-GLOBOCAN-2018--2018 (2018).
3. National Cancer Institute. Cancer stat facts: kidney and renal pelvis cancer. SEER https://seer.cancer.gov/statfacts/html/kidrp.html (2009).
4. Ebele, J., Sauter, G., Epstein, J. & Sesterhenn, I (eds) Pathology and Genetics of Tumours of the Urinary System and Male Genital Organs. (International Agency for Research on Cancer, 2004).
5. Rini, B. I. et al. Atezolizumab plus bevacizumab versus sunitinib in patients with previously untreated metastatic renal cell carcinoma (IMmotion151): a multicentre, open-label, phase 3, randomised controlled trial. Lancet 393, 2404–2415 (2019).